Huntsman shares fell 20% after an all-stock merger with Olin Corp. The deal's regulatory risk and Olin's 37 Alpha Score create a binary trade through year-end.
Alpha Score of 37 reflects weak overall profile with weak momentum, moderate value, poor quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Huntsman Corporation shares lost 20% on June 16 after the specialty chemical maker agreed to merge with Olin Corp in an all-stock transaction. The deal, announced after the close the previous day, values Huntsman at roughly $2.7 billion based on the exchange ratio, according to a joint statement from the two companies.
Huntsman shareholders will receive 0.75 Olin shares for each Huntsman share they hold. That exchange ratio set the floor for the drop. Olin shares also fell, down 4% on the session, trimming the implied value of the offer. The aggregate value of the deal fell with it.
The merger joins two chemical manufacturers with overlapping exposure to epoxy resins, polyurethanes, and caustic soda. Combined, they would control a larger share of the North American chlor-alkali and derivatives market. That overlap is the core risk for the deal's timeline. The Federal Trade Commission will review the transaction under the Hart-Scott-Rodino Act. A full second request, common in chemical mergers with concentrated product lines, could push the close past the companies' target of year-end 2025.
Olin's own fundamentals add another layer to the risk. AlphaScala's Alpha Score for Olin stands at 37 out of 100, labeled Mixed, in the Basic Materials sector. The score reflects a balanced set of signals: stable cash flows from chlorine and caustic soda operations offset by weak pricing in epoxy resins and elevated debt levels. The merger does not directly address those headwinds; it concentrates them under a larger balance sheet.
For Huntsman shareholders, the immediate risk is that the deal fails or gets renegotiated. A break-up fee of $150 million, disclosed in the merger agreement, would not compensate for a 20% price gap if the deal collapses. For Olin shareholders, the risk is execution: integrating two chemical platforms with different cost structures and customer bases, while managing the debt load needed to complete the merger.
The companies have scheduled a shareholder vote for late September. The FTC's review period could extend into October. Both stocks will trade on the deal's probability between now and then.
{OLN stock page}(/stocks/oln)
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.